Cargando…
MiR-34a and miR-206 act as novel prognostic and therapy biomarkers in cervical cancer
BACKGROUND: Recent evidence indicated that the aberrant expression of microRNA plays a crucial role in the development of cervical cancer. The overall shorter survival was strongly related to the abnormal expression of microRNA-34a (miR-34a) and microRNA-206 (miR-206), which target B cell lymphoma-2...
Autores principales: | Chen, Ai-Hua, Qin, Yu-E, Tang, Wen-Fan, Tao, Jing, Song, Hua-mei, Zuo, Manzhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466768/ https://www.ncbi.nlm.nih.gov/pubmed/28615991 http://dx.doi.org/10.1186/s12935-017-0431-9 |
Ejemplares similares
-
miR-206 as a prognostic and sensitivity biomarker for platinum chemotherapy in epithelial ovarian cancer
por: Yu, Xiaotang, et al.
Publicado: (2020) -
Knockdown of circRNA_0007534 suppresses the tumorigenesis of cervical cancer via miR-206/GREM1 axis
por: Sun, Qiang, et al.
Publicado: (2021) -
Associations between microRNA (miR-25, miR-32, miR-125, and miR-222) polymorphisms and recurrent implantation failure in Korean women
por: Lee, Jeong Yong, et al.
Publicado: (2019) -
Knockdown of lncRNA NEAT1 suppresses hypoxia-induced migration, invasion and glycolysis in anaplastic thyroid carcinoma cells through regulation of miR-206 and miR-599
por: Tan, Xiangrong, et al.
Publicado: (2020) -
FAIM Is Regulated by MiR-206, MiR-1-3p and MiR-133b
por: Coccia, Elena, et al.
Publicado: (2020)